Press release
Automated Cell Processing System Market to Reach USD 8.41 Billion by 2030
Automated Cell Processing System
Automated cell processing systems streamline and standardize cell isolation, expansion, activation, washing, concentration, and formulation-ensuring sterile, repeatable, and regulatory-compliant workflows across clinical and GMP environments.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73536
Key Takeaways
• Market Size 2023: USD 2.9 billion
• Market Size 2030: USD 8.41 billion
• CAGR (2024-2030): 16.4%
• Largest Segment: Cell therapy manufacturing automation
• Key Drivers: Growth of CAR-T, gene-modified therapies, GMP compliance, and reduced manual variability
Market Story
Cell therapy and regenerative medicine demand high-precision, sterile, and controllable cell processing workflows. Manual processes introduce variability, contamination risks, and scalability challenges. Automated systems deliver:
• Closed-system sterile processing
• Reduced labor and operator-dependent variability
• High scalability for autologous & allogeneic products
• Real-time monitoring and data integrity
• Seamless GMP compliance
• Consistent manufacturing outcomes
These technologies are increasingly used in:
• CAR-T cell therapy production
• TCR-T, NK cell, MSC & iPSC programs
• Stem cell expansion & differentiation
• Apheresis-derived cell processing
• Viral vector workflows
• Cell washing, concentration & formulation
• Biobank sample preparation
• Clinical manufacturing & CDMO operations
Automation is becoming mission-critical as global demand for personalized and allogeneic therapies skyrockets.
Market Segments
By System Type
• Automated Cell Processing Platforms (Largest Segment)
• Cell Expansion Systems (Bioreactor-Integrated)
• Cell Separation & Isolation Systems
• Apheresis Processing Systems
• Cell Washing & Concentration Equipment
• Cryopreservation & Formulation Systems
• Software & Digital Automation Tools
Integrated end-to-end systems are gaining traction in GMP facilities.
By Workflow/Application
• Cell Therapy Manufacturing (Largest Application)
- CAR-T, TCR-T, NK, MSC, iPSC
• Gene Therapy Processing
• Stem Cell Research & Regenerative Medicine
• Biobanking & Cell Preservation
• Clinical Sample Processing
• Apheresis Management
• Viral Vector Processing Support
Cell therapy manufacturing dominates due to increasing FDA/EMA approvals and clinical trial volume.
By End User
• Biopharmaceutical & Cell Therapy Companies (Largest End User)
• CDMOs (Fastest Growing)
• Academic & Research Institutes
• Hospital-Based Cell Therapy Centers
• Blood Banks & Biobanks
• CROs
CDMOs are accelerating adoption to support multi-client, multi-therapy production at scale.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73536/automated-cell-processing-system-market
Recent Industry Developments
• 2024 - Miltenyi Biotec expanded its CliniMACS Prodigy® automated cell manufacturing platform.
• 2023 - Thermo Fisher Scientific introduced modular automated systems for CAR-T and stem cell workflows.
• 2023 - Cytiva launched FlexFactoryTM-based automated cell therapy manufacturing lines.
• 2023 - Lonza enhanced its Cocoon® platform for decentralized, automated cell therapy production.
• 2023 - Beckman Coulter Life Sciences expanded automated cell isolation and washing capabilities.
Expert Quote
"Automation is fundamental to scaling modern cell therapies. It ensures sterility, consistency, and efficiency-key elements required for bringing advanced therapies from lab to commercial production."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
1. Rapid Growth of Cell & Gene Therapies
CAR-T, NK cell, TCR-T, MSC, and iPSC therapies demand precise and scalable processing.
2. Increasing GMP & Regulatory Expectations
Standardization, documentation, and contamination-free workflows are mandatory in clinical manufacturing.
3. Need for Scalability in Autologous & Allogeneic Workflows
Automation supports both personalized single-patient batches and large allogeneic programs.
4. Efficiency & Cost Reduction
Automated systems reduce labor, turnaround time, and risk of manual error.
5. Integration With Smart Manufacturing & PAT
Advanced sensors, closed systems, and AI-based monitoring improve product yield and quality.
Forecast Outlook (2024-2030)
Key trends shaping the market include:
• Decentralized cell manufacturing units powered by automated systems
• Closed, end-to-end automated platforms for full cell therapy workflows
• AI-driven optimization of cell expansion & differentiation
• Single-use automated systems
• Increased collaboration between CDMOs and hospitals
• Automation for advanced gene-edited therapies (CRISPR-based products)
By 2030, fully automated, closed-loop systems will become the backbone of global cell therapy manufacturing.
Regional Insights
North America
Largest market due to strong cell therapy pipelines, large CDMO presence, and technology adoption.
Europe
High adoption driven by advanced research institutions and cell therapy manufacturing hubs.
Asia-Pacific (Fastest Growing Region)
China, Japan, South Korea, Singapore, and India are rapidly expanding cell therapy manufacturing capabilities.
Latin America & Middle East
Emerging adoption driven by growing clinical infrastructure and investment in regenerative medicine.
Conclusion
The Automated Cell Processing System Market is set for high-momentum growth as advanced therapies scale globally. Automation enables reproducibility, sterility, and GMP-compliant production-making it indispensable for the future of cell & gene therapy manufacturing.
This report is also available in the following languages : Japanese (自動細胞処理システム市場), Korean (자동 세포 처리 시스템 시장), Chinese (自动化细胞处理系统市场), French (Marché des systèmes automatisés de traitement cellulaire), German (Markt für automatisierte Zellverarbeitungssysteme), and Italian (Mercato dei sistemi di elaborazione cellulare automatizzati), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73536
Related Reports
Pure Suspension Cell Culture Medium Market
https://exactitudeconsultancy.com/reports/75281/pure-suspension-cell-culture-medium-market
Global Automated Cell Washing Centrifuge Market
https://exactitudeconsultancy.com/reports/58786/global-automated-cell-washing-centrifuge-market
Global Portable Cell Counter Market
https://exactitudeconsultancy.com/reports/59400/global-portable-cell-counter-market
Global Cell Roller Bottles Market
https://exactitudeconsultancy.com/reports/61347/global-cell-roller-bottles-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Automated Cell Processing System Market to Reach USD 8.41 Billion by 2030 here
News-ID: 4293163 • Views: …
More Releases from Exactitude Consultancy
Single-Use Bioreactors Market to Reach USD 14.9 Billion by 2030
The Global Single-Use Bioreactors Market is expanding rapidly as biopharmaceutical manufacturers, CDMOs, and advanced therapy producers increasingly choose disposable bioreactors over traditional stainless-steel systems. According to Exactitude Consultancy, the market size is projected to rise from USD 5.4 billion in 2023 to USD 14.9 billion by 2030, achieving a strong CAGR of 15.4%.
Single-use bioreactors (SUBs) enable flexible, contamination-resistant, and cost-efficient production-making them essential for mAbs, vaccines, recombinant proteins, viral vectors,…
Continuous Manufacturing Systems Market to Reach USD 2.98 Billion by 2030
The Global Continuous Manufacturing Systems Market is expanding rapidly as industries shift from traditional batch processing to real-time, efficient, and automation-driven continuous production. According to Exactitude Consultancy, the market is projected to increase from USD 1.42 billion in 2023 to USD 2.98 billion by 2030, growing at a notable CAGR of 10.6%.
Continuous manufacturing systems are increasingly deployed in pharmaceuticals, chemicals, food processing, and advanced materials due to their benefits in…
Continuous Bioprocessing Market to Reach USD 18.6 Billion by 2030
The Global Continuous Bioprocessing Market is accelerating as biologics, biosimilars, vaccines, and emerging cell & gene therapies increasingly adopt continuous, real-time, and highly controlled manufacturing approaches. According to Exactitude Consultancy, the market is expected to grow from USD 6.2 billion in 2023 to USD 18.6 billion by 2030, registering an impressive CAGR of 16.9%.
Continuous bioprocessing enables uninterrupted production, improved efficiency, reduced footprint, lower costs, and superior product consistency compared to…
Bioprocess Automation Market to Reach USD 33.4 Billion by 2030
The Global Bioprocess Automation Market is experiencing rapid expansion as biologics, biosimilars, cell therapies, gene therapies, and vaccine manufacturing increasingly rely on automated, connected, and highly controlled bioprocessing systems. According to Exactitude Consultancy, the market is projected to grow from USD 12.4 billion in 2023 to USD 33.4 billion by 2030, achieving a strong CAGR of 14.2%.
Automation across upstream, downstream, and fill-finish workflows ensures higher productivity, reduced contamination, improved batch…
More Releases for Cell
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
